LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,836,352 | -2.6% | 4,050,218 | +2.3% | 1.35% | -14.0% |
| Q2 2023 | $16,265,497 | +264.4% | 3,957,542 | +78.2% | 1.57% | +359.9% |
| Q1 2023 | $4,463,868 | -36.0% | 2,220,830 | 0.0% | 0.34% | -24.3% |
| Q4 2022 | $6,973,406 | -38.0% | 2,220,830 | -1.1% | 0.45% | -37.9% |
| Q3 2022 | $11,252,000 | -16.0% | 2,245,830 | -5.2% | 0.73% | +8.5% |
| Q2 2022 | $13,389,000 | – | 2,369,668 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|